IV 
118TH CONGRESS 
1ST SESSION 
H. RES. 709 
Supporting the designation of September 2023 as ‘‘National Cholesterol 
Education Month’’, and September 30, 2023, as LDL–C Awareness Day. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 20, 2023 
Mrs. CHERFILUS-MCCORMICK (for herself, Mrs. CAMMACK, Ms. ADAMS, Mr. 
CLEAVER, Mr. GARCI´A of Illinois, Ms. SCHAKOWSKY, Mr. PAYNE, Mr. 
GREEN of Texas, Ms. KUSTER, Ms. BLUNT ROCHESTER, Mr. VEASEY, 
and Mr. JOHNSON of Georgia) submitted the following resolution; which 
was referred to the Committee on Energy and Commerce 
RESOLUTION 
Supporting the designation of September 2023 as ‘‘National 
Cholesterol Education Month’’, and September 30, 2023, 
as LDL–C Awareness Day. 
Whereas cardiovascular disease is the leading cause of death 
for men and women, including people of color in the 
United States, who have higher rates of cardiovascular 
disease and tend to develop this condition at an earlier 
age than non-Hispanic White populations; 
Whereas cardiovascular disease disproportionately affects un-
derserved populations as 52.3 percent of Hispanic men 
and 42.7 percent of Hispanic women over the age of 20 
have cardiovascular disease, and 60.1 percent of Black 
VerDate Sep 11 2014 
23:07 Sep 22, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR709.IH
HR709
lotter on DSK11XQN23PROD with BILLS
•HRES 709 IH 
men and 58.8 percent of Black women 20 years of age 
and older have cardiovascular disease; 
Whereas projected rates of cardiovascular disease are ex-
pected to increase significantly in the United States by 
2060, disproportionately affecting communities of color; 
Whereas women’s awareness of cardiovascular disease as the 
leading cause of death has declined by approximately 20 
percent in the last decade, most significantly among 
younger women; 
Whereas rural places in the United States have higher death 
rates for cardiovascular disease and stroke, as well as a 
40-percent higher prevalence of cardiovascular disease 
than its urban counterparts; 
Whereas rural women experience higher maternal mortality 
rates compared to urban women, driven largely by in-
creased cardiovascular deaths; 
Whereas risk factors contributing to cardiovascular disease 
and poor health outcomes include elevated low density 
lipoprotein ‘‘bad’’ cholesterol (LDL–C), high levels of 
lipoprotein(a) cholesterol, hypertension, obesity, low 
awareness of personal risk factors, genetics, geographic 
location, and inequitable access to care; 
Whereas lipoprotein(a) cholesterol is predominantly geneti-
cally inherited and can build up in the walls of blood ves-
sels creating cholesterol deposits, or plaques, and lead to 
atherosclerotic cardiovascular disease; 
Whereas LDL–C is a modifiable risk factor for cardio-
vascular disease and lower LDL–C is associated with a 
reduced risk of heart attack and stroke; 
Whereas more than 25.5 percent of adults in the United 
States have high LDL–C; 
VerDate Sep 11 2014 
00:50 Sep 21, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR709.IH
HR709
lotter on DSK11XQN23PROD with BILLS
•HRES 709 IH 
Whereas more than 200 studies with over 2,000,000 patients 
have broadly established that elevated LDL–C unequivo-
cally causes atherosclerotic cardiovascular disease; 
Whereas atherosclerotic cardiovascular disease, which is re-
sponsible for nearly 85 percent of cardiovascular deaths, 
is the build-up of cholesterol plaque within the walls of 
arteries and includes acute coronary syndrome, peripheral 
arterial disease, and events such as heart attacks and 
strokes; 
Whereas the resources needed to bend the curve in cardio-
vascular 
disease 
exist, 
yet 
percent 
of 
hypercholesterolemia patients at high risk of a cardio-
vascular event never achieve recommended LDL–C treat-
ment guideline thresholds; 
Whereas only 33 percent of people with atherosclerotic car-
diovascular disease who are taking statins, a guideline 
recommended lipid lowering therapy, actually achieve 
LDL–C goals; 
Whereas only 27 percent of patients hospitalized for heart at-
tack receive an LDL–C test in the 90 days following dis-
charge from a hospital, as recommended by clinical 
guidelines; 
Whereas African-American adults were less likely than their 
White peers to receive an LDL–C test in the 90 days fol-
lowing discharge from a hospital, despite having a higher 
prevalence of cardiovascular disease; 
Whereas significant gaps in care lead to subsequent cardio-
vascular events; 
Whereas the Centers for Disease Control and Prevention’s 
Million Hearts program seeks to improve access to and 
VerDate Sep 11 2014 
00:50 Sep 21, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HR709.IH
HR709
lotter on DSK11XQN23PROD with BILLS
•HRES 709 IH 
quality of care to reduce heart disease, stroke, and death; 
and 
Whereas September is recognized as National Cholesterol 
Education Month to raise awareness of cardiovascular 
disease and the importance of knowing one’s LDL–C 
number: Now, therefore, be it 
Resolved, That the House of Representatives— 
(1) encourages all people in the United States 
to know their LDL–C number; and 
(2) recognizes the urgent need for screening 
and treating of LDL–C to reduce the risk of cardio-
vascular disease and cardiovascular events such as 
heart attacks or strokes. 
Æ 
VerDate Sep 11 2014 
00:50 Sep 21, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR709.IH
HR709
lotter on DSK11XQN23PROD with BILLS